Thiago Carvalho on Nostr: 'Part of the aim of the metformin trial is to persuade the US Food and Drug ...
'Part of the aim of the metformin trial is to persuade the US Food and Drug Administration to approve ageing as an “indication”, to signify that it can be “treated”. It is struggling to raise enough funding for clinical trials, because metformin is a generic drug, so offers insufficient profit to pharmaceutical companies.'
https://www.ft.com/content/bb0a8eb7-227a-400a-919a-ab7dd2f20f0bPublished at
2024-04-27 17:11:28Event JSON
{
"id": "332ed70ea97a58f65085744ab9783fbd0dd6af76ce0d1a3108c33ff587a7a45a",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1714237888,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/112344294259570100",
"activitypub"
]
],
"content": "'Part of the aim of the metformin trial is to persuade the US Food and Drug Administration to approve ageing as an “indication”, to signify that it can be “treated”. It is struggling to raise enough funding for clinical trials, because metformin is a generic drug, so offers insufficient profit to pharmaceutical companies.'\n\nhttps://www.ft.com/content/bb0a8eb7-227a-400a-919a-ab7dd2f20f0b",
"sig": "656d695fce1a54228471f242c061295026171c799ecaee27e82858798840f23e78512c459c4fea768bd874b1753581d0d262d72a8ab6271a1900904b82d00b33"
}
